EKF Diagnostics Holdings PLC Result of General Meeting (2974M)
July 27 2017 - 6:18AM
UK Regulatory
TIDMEKF
RNS Number : 2974M
EKF Diagnostics Holdings PLC
27 July 2017
EKF Diagnostics Holdings plc
("EKF", the "Company")
Result of General Meeting
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical
diagnostics business, announces that at the general meeting of the
Company held today the resolutions to cancel the share premium
account of the Company and to grant the Company the general
authority to make market purchases of its own shares were
passed.
As previously announced, the cancellation is necessary in order
for the Company to proceed with its share buyback plan of up to 15%
of the Company's current issued share capital.
The Company is currently making the necessary court applications
to enable it to proceed with the share buyback and will issue
further updates at the appropriate time.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Tel: 029 2071 0570
Chairman
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Alex Price / Shaun Dobson
/ Ali Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMBDLFLDDFFBBQ
(END) Dow Jones Newswires
July 27, 2017 06:18 ET (10:18 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024